EP3368017
Hámörkuð tafla með háum skammti af mesalasíni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.10.2016EP published:
6.11.2019EP application number:
16787790.1
EP translation filed:
2.12.2019Grant published:
15.12.2019EPO information:
European Patent Register
Max expiry date:
20.10.2036Expiry date:
20.10.2026Next due date:
31.10.2026
Title:
OPTIMIZED HIGH-DOSE TABLET OF MESALAZINE
Timeline
Today
21.10.2016EP application
6.11.2019EP Publication
2.12.2019Translation submitted
15.12.2019Registration published
20.10.2026Expires
Owner
Name:
Dr. Falk Pharma GmbHAddress:
Leinenweberstrasse 5, 79108, Freiburg, DE
Inventor
Name:
WILHELM, RudolphAddress:
Bischweier, DE
Name:
PRÖLS, MarkusAddress:
Freiburg/Breisgau, DE
Name:
GREINWALD, RolandAddress:
Kenzingen, DE
Name:
NACAK, TanjuAddress:
Gottenheim, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
15192269Date:
30.10.2015Country:
EP
Classification
Categories:
A61K 9/20, A61K 9/28, A61K 31/606
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 16.10.2020
Expires: 20.10.2021
Payer: Patice ehf.
Number: 6
Paid: 18.10.2021
Expires: 20.10.2022
Payer: Patice ehf.
Number: 7
Paid: 25.10.2022
Expires: 20.10.2023
Payer: Patice ehf.
Number: 8
Paid: 31.10.2023
Expires: 20.10.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 22.10.2024
Expires: 20.10.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.10.2025
Expires: 20.10.2026
Payer: Árnason Faktor ehf.